BR112013020734A2 - composições e métodos para alterar a especificidade do tecido e aprimorar a transferência gênica mediada por aav9 - Google Patents
composições e métodos para alterar a especificidade do tecido e aprimorar a transferência gênica mediada por aav9Info
- Publication number
- BR112013020734A2 BR112013020734A2 BR112013020734A BR112013020734A BR112013020734A2 BR 112013020734 A2 BR112013020734 A2 BR 112013020734A2 BR 112013020734 A BR112013020734 A BR 112013020734A BR 112013020734 A BR112013020734 A BR 112013020734A BR 112013020734 A2 BR112013020734 A2 BR 112013020734A2
- Authority
- BR
- Brazil
- Prior art keywords
- aav9
- enhancing
- compositions
- methods
- gene transfer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14041—Use of virus, viral particle or viral elements as a vector
- C12N2750/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14041—Use of virus, viral particle or viral elements as a vector
- C12N2750/14045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6027—Vectors comprising as targeting moiety peptide derived from defined protein from viruses ssDNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161443879P | 2011-02-17 | 2011-02-17 | |
| PCT/US2012/025550 WO2012112832A1 (en) | 2011-02-17 | 2012-02-17 | Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013020734A2 true BR112013020734A2 (pt) | 2017-06-13 |
Family
ID=45757234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013020734A BR112013020734A2 (pt) | 2011-02-17 | 2012-02-17 | composições e métodos para alterar a especificidade do tecido e aprimorar a transferência gênica mediada por aav9 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9884071B2 (pt) |
| EP (1) | EP2675902B1 (pt) |
| JP (1) | JP6224459B2 (pt) |
| KR (1) | KR101956885B1 (pt) |
| CN (1) | CN103502458B (pt) |
| AU (1) | AU2012219380B2 (pt) |
| BR (1) | BR112013020734A2 (pt) |
| CA (1) | CA2826316C (pt) |
| DK (1) | DK2675902T3 (pt) |
| ES (1) | ES2724800T3 (pt) |
| HU (1) | HUE043921T2 (pt) |
| MX (1) | MX353930B (pt) |
| PL (1) | PL2675902T3 (pt) |
| SG (3) | SG10202007803QA (pt) |
| TR (1) | TR201908020T4 (pt) |
| WO (1) | WO2012112832A1 (pt) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3211085T (pt) * | 2003-09-30 | 2021-06-17 | Univ Pennsylvania | Clados de vírus adeno-associados (aav), sequências, vetores que as contêm, e suas utilizações |
| US9217155B2 (en) | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| EP3444346B1 (en) | 2010-04-23 | 2022-07-27 | University of Massachusetts | Aav-based treatment of cholesterol-related disorders |
| WO2011133890A1 (en) | 2010-04-23 | 2011-10-27 | University Of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| WO2012109570A1 (en) | 2011-02-10 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| EP2675902B1 (en) | 2011-02-17 | 2019-03-27 | The Trustees Of The University Of Pennsylvania | Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
| EP3318634A1 (en) | 2011-04-21 | 2018-05-09 | University of Massachusetts | Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations |
| EP3470523A1 (en) * | 2012-05-09 | 2019-04-17 | Oregon Health & Science University | Adeno associated virus plasmids and vectors |
| EP2749569A1 (en) | 2012-12-28 | 2014-07-02 | Annibale Alessandro Puca | Variant of BPIFB4 protein |
| US20140219964A1 (en) * | 2013-02-07 | 2014-08-07 | Children's Medical Center Corporation | Methods for inducing cardiomyocyte proliferation |
| AU2014244167A1 (en) * | 2013-03-13 | 2015-10-08 | The Children's Hospital Of Philadelphia | Adeno-associated virus vectors and methods of use thereof |
| ES2805355T3 (es) | 2013-03-15 | 2021-02-11 | Univ Pennsylvania | Composiciones para tratar MPSI |
| DK2968605T3 (da) * | 2013-03-15 | 2022-09-26 | Univ North Carolina Chapel Hill | Fremgangsmåder og sammensætninger til dobbelte glycanbindende aav-vektorer |
| HUE046454T2 (hu) | 2014-03-21 | 2020-03-30 | Genzyme Corp | Retinitis pigmentosa génterápia |
| US10746742B2 (en) | 2014-04-25 | 2020-08-18 | Oregon Health & Science University | Methods of viral neutralizing antibody epitope mapping |
| US10689653B2 (en) | 2014-06-03 | 2020-06-23 | University Of Massachusetts | Compositions and methods for modulating dysferlin expression |
| US10577627B2 (en) | 2014-06-09 | 2020-03-03 | Voyager Therapeutics, Inc. | Chimeric capsids |
| CA2961523A1 (en) | 2014-09-16 | 2016-03-24 | Genzyme Corporation | Adeno-associated viral vectors for treating myocilin (myoc) glaucoma |
| EP4012035A1 (en) | 2014-09-16 | 2022-06-15 | Genzyme Corporation | Adeno-associated viral vectors for treating myocilin (myoc) glaucoma |
| US10370432B2 (en) | 2014-10-03 | 2019-08-06 | University Of Massachusetts | Heterologous targeting peptide grafted AAVS |
| EP3200830B1 (en) | 2014-10-03 | 2020-09-09 | University of Massachusetts | High efficiency library-identified aav vectors |
| CN107073051B (zh) | 2014-10-21 | 2021-08-24 | 马萨诸塞大学 | 重组aav变体及其用途 |
| CN112553229A (zh) | 2014-11-05 | 2021-03-26 | 沃雅戈治疗公司 | 用于治疗帕金森病的aadc多核苷酸 |
| KR102599909B1 (ko) | 2014-11-14 | 2023-11-09 | 보이저 테라퓨틱스, 인크. | 근위축성 측삭 경화증(als)을 치료하는 조성물 및 방법 |
| DK3218386T3 (da) | 2014-11-14 | 2021-06-07 | Voyager Therapeutics Inc | Modulatorisk polynukleotid |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| CA2974378A1 (en) | 2015-01-20 | 2016-07-28 | Genzyme Corporation | Analytical ultracentrifugation for characterization of recombinant viral particles |
| PT3256594T (pt) | 2015-02-10 | 2022-01-18 | Genzyme Corp | Entrega intensificada de partículas virais ao corpo estriado e córtex |
| WO2016130589A2 (en) | 2015-02-10 | 2016-08-18 | Genzyme Corporation | VARIANT RNAi |
| US10584321B2 (en) | 2015-02-13 | 2020-03-10 | University Of Massachusetts | Compositions and methods for transient delivery of nucleases |
| TWI707951B (zh) | 2015-04-08 | 2020-10-21 | 美商健臻公司 | 過大腺相關載體之製造 |
| WO2016172008A1 (en) | 2015-04-24 | 2016-10-27 | University Of Massachusetts | Modified aav constructions and uses thereof |
| RU2021132397A (ru) | 2015-05-16 | 2022-02-24 | Джензим Корпорейшн | Генное редактирование глубоких интронных мутаций |
| CA2988471A1 (en) * | 2015-07-28 | 2017-02-02 | University Of Massachusetts | Transgenic expression of dnase i in vivo delivered by an adeno-associated virus vector |
| WO2017070516A1 (en) | 2015-10-22 | 2017-04-27 | University Of Massachusetts | Prostate-targeting adeno-associated virus serotype vectors |
| EP3364997B1 (en) | 2015-10-22 | 2024-01-17 | University of Massachusetts | Aspartoacylase gene therapy in the treatment of canavan disease |
| EP3384035A4 (en) | 2015-12-02 | 2019-08-07 | Voyager Therapeutics, Inc. | ASSAYS FOR DETECTION OF NEUTRALIZING ANTIBODIES OF VAA |
| WO2017100676A1 (en) | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav8 |
| US11015173B2 (en) | 2015-12-11 | 2021-05-25 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV1 |
| EP3387138B1 (en) | 2015-12-11 | 2022-01-26 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| ES2918998T3 (es) | 2015-12-11 | 2022-07-21 | Univ Pennsylvania | Método de purificación escalable para AAVrh10 |
| KR20180098294A (ko) | 2015-12-15 | 2018-09-03 | 젠자임 코포레이션 | 뮤코지질증 ii형을 치료하기 위한 아데노-관련 바이러스 벡터 |
| CA3011939A1 (en) | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| US10973929B2 (en) | 2016-02-03 | 2021-04-13 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type I |
| EP4094780A3 (en) | 2016-02-12 | 2023-02-08 | University of Massachusetts | Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization |
| WO2017176929A1 (en) | 2016-04-05 | 2017-10-12 | University Of Massachusetts | Compositions and methods for selective inhibition of grainyhead-like protein expression |
| SG10201912761UA (en) | 2016-04-15 | 2020-02-27 | The Trustees Of The Univ Of Pennsyvania | Gene therapy for treating mucopolysaccharidosis type ii |
| US11413356B2 (en) | 2016-04-15 | 2022-08-16 | University Of Massachusetts | Methods and compositions for treating metabolic imbalance |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| WO2017189959A1 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| ES2941502T3 (es) | 2016-05-13 | 2023-05-23 | 4D Molecular Therapeutics Inc | Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas |
| AU2017267665C1 (en) | 2016-05-18 | 2023-10-05 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| CA3024449A1 (en) | 2016-05-18 | 2017-11-23 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
| US11882815B2 (en) | 2016-06-15 | 2024-01-30 | University Of Massachusetts | Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells |
| CN106093369B (zh) * | 2016-06-29 | 2017-10-20 | 福建农林大学 | Bt水稻对非靶标害虫褐飞虱的安全性评价方法 |
| MX2019001938A (es) | 2016-08-15 | 2019-07-04 | Genzyme Corp | Metodos para detectar aav. |
| AU2017321488B2 (en) | 2016-08-30 | 2022-10-20 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| US10457940B2 (en) | 2016-09-22 | 2019-10-29 | University Of Massachusetts | AAV treatment of Huntington's disease |
| US11578340B2 (en) | 2016-10-13 | 2023-02-14 | University Of Massachusetts | AAV capsid designs |
| AU2018261003A1 (en) | 2017-05-05 | 2019-11-14 | Voyager Therapeutics, Inc. | Compositions and methods of treating Huntington's Disease |
| US11603542B2 (en) | 2017-05-05 | 2023-03-14 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| US11890329B2 (en) | 2017-07-06 | 2024-02-06 | The Trustees Of The University Of Pennsylvania | AAV9-mediated gene therapy for treating mucopolysaccharidosis type I |
| AU2018302016A1 (en) | 2017-07-17 | 2020-02-06 | The Regents Of The University Of California | Trajectory array guide system |
| SG11202002276VA (en) | 2017-09-20 | 2020-04-29 | 4D Molecular Therapeutics Inc | Adeno-associated virus variant capsids and methods of use thereof |
| SG11202002457RA (en) | 2017-09-22 | 2020-04-29 | Univ Pennsylvania | Gene therapy for treating mucopolysaccharidosis type ii |
| BR112020005569A2 (pt) | 2017-09-22 | 2020-10-06 | Genzyme Corporation | rna de interferência (rnai) variante |
| TWI804518B (zh) | 2017-10-16 | 2023-06-11 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| EP4272728A2 (en) | 2017-11-27 | 2023-11-08 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and use for inhibiting angiogenesis |
| CN111886021A (zh) * | 2018-02-01 | 2020-11-03 | 同源药物公司 | 用于pah基因转移的腺伴随病毒组合物及其使用方法 |
| US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| JP7244547B2 (ja) | 2018-02-19 | 2023-03-22 | ホモロジー・メディシンズ・インコーポレイテッド | Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法 |
| JP7374119B2 (ja) | 2018-04-05 | 2023-11-06 | ジェネトン | 減少した肝臓向性を有するＡＡＶ９とＡＡＶｒｈ７４とのハイブリッド組換えアデノ随伴ウイルス血清型 |
| JP2021523702A (ja) * | 2018-05-04 | 2021-09-09 | オレゴン ヘルス アンド サイエンス ユニバーシティ | ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ |
| EP3807404A1 (en) | 2018-06-13 | 2021-04-21 | Voyager Therapeutics, Inc. | Engineered 5' untranslated regions (5' utr) for aav production |
| MX2021000810A (es) | 2018-07-24 | 2021-04-28 | Voyager Therapeutics Inc | Sistemas y metodos para producir formulaciones de terapia genetica. |
| KR20210062627A (ko) | 2018-08-03 | 2021-05-31 | 젠자임 코포레이션 | 알파-시뉴클레인에 대한 변이형 RNAi |
| TW202035689A (zh) | 2018-10-04 | 2020-10-01 | 美商航海家醫療公司 | 測量病毒載體粒子的效價及強度之方法 |
| SG11202103425YA (en) | 2018-10-05 | 2021-05-28 | Voyager Therapeutics Inc | Engineered nucleic acid constructs encoding aav production proteins |
| JP2022504740A (ja) | 2018-10-12 | 2022-01-13 | ジェンザイム・コーポレーション | 肝臓に向けられた遺伝子補充療法によって重度のｐｋｕを処置するための改善されたヒトｐａｈの生成 |
| UY38407A (es) | 2018-10-15 | 2020-05-29 | Novartis Ag | Anticuerpos estabilizadores de trem2 |
| WO2020081490A1 (en) | 2018-10-15 | 2020-04-23 | Voyager Therapeutics, Inc. | EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM |
| EP3917566A4 (en) | 2019-01-31 | 2022-10-26 | Oregon Health & Science University | METHODS OF USING DIRECTED, TRANSCRIPTION-DEPENDENT EVOLUTION OF AAV CAPSIDS |
| BR112021016501A2 (pt) | 2019-02-25 | 2021-10-26 | Novartis Ag | Composições e métodos para tratar distrofia cristalina de bietti |
| EP3931335A2 (en) | 2019-02-25 | 2022-01-05 | Novartis AG | Compositions and methods to treat bietti crystalline dystrophy |
| CA3131919A1 (en) | 2019-02-28 | 2020-09-03 | Regeneron Pharmaceuticals, Inc. | Adeno-associated virus vectors for the delivery of therapeutics |
| CN114008209A (zh) * | 2019-04-12 | 2022-02-01 | 马萨诸塞大学 | Aav介导的枫糖尿症(msud)基因疗法 |
| US10653731B1 (en) | 2019-07-15 | 2020-05-19 | Vigene Biosciences Inc. | Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency |
| US10557149B1 (en) | 2019-07-15 | 2020-02-11 | Vigene Biosciences, Inc. | Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus |
| US10801042B1 (en) | 2019-07-15 | 2020-10-13 | Vigene Biosciences, Inc. | Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus |
| US20230079440A1 (en) * | 2019-11-01 | 2023-03-16 | Sangamo Therapeutics, Inc. | Compositions and methods for genome engineering |
| TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| CA3193866A1 (en) | 2020-10-01 | 2022-04-07 | Sirkka R.M. Kyostio-Moore | Human pah expression cassette for treatment of pku by liver-directed gene replacement therapy |
| AU2022214429A1 (en) | 2021-02-01 | 2023-09-14 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| CA3227103A1 (en) | 2021-07-30 | 2023-02-02 | Matthew P. GEMBERLING | Compositions and methods for modulating expression of frataxin (fxn) |
| AU2022318664A1 (en) | 2021-07-30 | 2024-02-29 | Tune Therapeutics, Inc. | Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2) |
| WO2023147304A1 (en) * | 2022-01-25 | 2023-08-03 | The Trustees Of The University Of Pennsylvania | Aav capsids for improved heart transduction and detargeting of liver |
| WO2023214346A1 (en) | 2022-05-06 | 2023-11-09 | Novartis Ag | Novel recombinant aav vp2 fusion polypeptides |
| WO2024015881A2 (en) | 2022-07-12 | 2024-01-18 | Tune Therapeutics, Inc. | Compositions, systems, and methods for targeted transcriptional activation |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5774090A (en) | 1980-10-27 | 1982-05-10 | Shionogi & Co Ltd | Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production |
| US4886876A (en) | 1983-03-31 | 1989-12-12 | Scripps Clinic And Research Foundation | Factor VIII coagulant polypeptides |
| US4542104A (en) | 1983-04-06 | 1985-09-17 | The Board Of Trustees Of The Leland Stanford Jr. Univ. | Phycobiliprotein fluorescent conjugates |
| WO1985001961A1 (en) | 1983-10-28 | 1985-05-09 | Genetics Institute | Production of factor viii and related products |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US5045455A (en) | 1984-01-12 | 1991-09-03 | Chiron Corporation | Factor VIII:C cDNA cloning and expression |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| FI86885C (fi) | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
| EP0182448A3 (en) | 1984-08-24 | 1987-10-28 | Genetics Institute, Inc. | Production of factor viii and related products |
| US5595886A (en) | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
| FI98829C (fi) | 1986-01-27 | 1997-08-25 | Chiron Corp | Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta |
| US5422260A (en) | 1986-05-29 | 1995-06-06 | Genetics Institute, Inc. -Legal Affairs | Human factor VIII:c muteins |
| US5451521A (en) | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
| US5149637A (en) | 1987-04-06 | 1992-09-22 | Scripps Clinic & Research Foundation | Recombinant Factor VIIIC fragments |
| IE69026B1 (en) | 1987-06-12 | 1996-08-07 | Immuno Ag | Novel proteins with factor VIII activity process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
| FR2619314B1 (fr) | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
| US5004803A (en) | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
| KR960701899A (ko) | 1989-11-17 | 1996-03-28 | 안네 제케르 | 인자 viii:c활성을 갖는 단백질 복합체 및 그의 제조 |
| SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| US5272257A (en) | 1990-05-21 | 1993-12-21 | Coulter Corporation | Method of preferential labelling of a phycobiliprotein with an amine-reactive dye for use in a multiple color assay and product for such use |
| US5171846A (en) | 1990-05-21 | 1992-12-15 | Coulter Corporation | Method of preferential labelling of a phycobiliprotein with a second dye for use in a multiple color assay and product for such use |
| US5240640A (en) | 1990-06-04 | 1993-08-31 | Coulter Corporation | In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles |
| US5639620A (en) | 1990-10-31 | 1997-06-17 | Coulter Corporation | Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same |
| US5466609A (en) | 1990-10-31 | 1995-11-14 | Coulter Corporation | Biodegradable gelatin-aminodextran particle coatings of and processes for making same |
| US5661008A (en) | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
| SE468050C (sv) | 1991-03-15 | 1998-02-11 | Pharmacia & Upjohn Ab | Rekombinant derivat av human faktor VIII |
| US5248771A (en) | 1991-06-26 | 1993-09-28 | Triumf | Process for preparing no-carrier-added radiohalogenated vinyl nucleosides |
| CA2078721A1 (en) | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
| US5248772A (en) | 1992-01-29 | 1993-09-28 | Coulter Corporation | Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| WO1994011013A1 (en) | 1992-11-13 | 1994-05-26 | Duke University | Chimeric blood coagulation proteins |
| US5563045A (en) | 1992-11-13 | 1996-10-08 | Genetics Institute, Inc. | Chimeric procoagulant proteins |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| ES2226029T3 (es) | 1993-06-10 | 2005-03-16 | Bayer Corporation | Vector y linea celular de mamifero con productividad mejorada. |
| DE69433087T2 (de) | 1993-06-11 | 2004-06-09 | Coulter International Corp., Miami | Anti-cd3-antikörper-aminodextran-konjugate zur induktion der t-zellen-aktivierung und vermehrung |
| US5681746A (en) | 1994-12-30 | 1997-10-28 | Chiron Viagene, Inc. | Retroviral delivery of full length factor VIII |
| WO1997003195A1 (en) | 1995-07-11 | 1997-01-30 | Chiron Corporation | Novel factor viii:c polypeptide analogs with altered protease sites |
| IL128780A0 (en) | 1996-09-06 | 2000-01-31 | Univ Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase |
| US6096273A (en) | 1996-11-05 | 2000-08-01 | Clinical Micro Sensors | Electrodes linked via conductive oligomers to nucleic acids |
| US5945293A (en) | 1997-10-09 | 1999-08-31 | Coulter International Corp. | Protein-colloidal metal-aminodextran coated particle and methods of preparation and use |
| US6074884A (en) | 1997-10-09 | 2000-06-13 | Coulter International Corp. | Stable protein-nickel particles and methods of production and use thereof |
| US6117643A (en) | 1997-11-25 | 2000-09-12 | Ut Battelle, Llc | Bioluminescent bioreporter integrated circuit |
| US6197503B1 (en) | 1997-11-26 | 2001-03-06 | Ut-Battelle, Llc | Integrated circuit biochip microsystem containing lens |
| US6287857B1 (en) * | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
| DE69916421T2 (de) | 1998-09-09 | 2005-03-24 | Hitachi Software Engineering Co., Ltd., Yokohama | Biochip und verfahren zur verwendung des biochips |
| US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| US6221349B1 (en) | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
| PT3211085T (pt) * | 2003-09-30 | 2021-06-17 | Univ Pennsylvania | Clados de vírus adeno-associados (aav), sequências, vetores que as contêm, e suas utilizações |
| WO2006119432A2 (en) * | 2005-04-29 | 2006-11-09 | The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services | Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes |
| PL2425000T3 (pl) | 2009-04-30 | 2019-08-30 | The Trustees Of The University Of Pennsylvania | Kompozycje do kierowania komórek przewodzących do dróg oddechowych zawierające konstrukty wirusów związanych z adenowirusami |
| JP5458245B2 (ja) | 2010-06-25 | 2014-04-02 | 国立大学法人九州工業大学 | 動作制御装置、その方法、及びプログラム |
| WO2012109214A1 (en) | 2011-02-07 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Targeted transduction of aav vectors |
| WO2012109570A1 (en) | 2011-02-10 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| EP2675902B1 (en) | 2011-02-17 | 2019-03-27 | The Trustees Of The University Of Pennsylvania | Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
-
2012
- 2012-02-17 EP EP12705773.5A patent/EP2675902B1/en active Active
- 2012-02-17 WO PCT/US2012/025550 patent/WO2012112832A1/en active Application Filing
- 2012-02-17 AU AU2012219380A patent/AU2012219380B2/en active Active
- 2012-02-17 SG SG10202007803QA patent/SG10202007803QA/en unknown
- 2012-02-17 BR BR112013020734A patent/BR112013020734A2/pt not_active Application Discontinuation
- 2012-02-17 SG SG2013058920A patent/SG192268A1/en unknown
- 2012-02-17 KR KR1020137023589A patent/KR101956885B1/ko active IP Right Grant
- 2012-02-17 CA CA2826316A patent/CA2826316C/en active Active
- 2012-02-17 US US13/985,630 patent/US9884071B2/en active Active
- 2012-02-17 PL PL12705773T patent/PL2675902T3/pl unknown
- 2012-02-17 JP JP2013554622A patent/JP6224459B2/ja active Active
- 2012-02-17 DK DK12705773.5T patent/DK2675902T3/da active
- 2012-02-17 MX MX2013009538A patent/MX353930B/es active IP Right Grant
- 2012-02-17 SG SG10201601110VA patent/SG10201601110VA/en unknown
- 2012-02-17 TR TR2019/08020T patent/TR201908020T4/tr unknown
- 2012-02-17 CN CN201280008862.8A patent/CN103502458B/zh active Active
- 2012-02-17 ES ES12705773T patent/ES2724800T3/es active Active
- 2012-02-17 HU HUE12705773A patent/HUE043921T2/hu unknown
-
2018
- 2018-01-05 US US15/862,999 patent/US10406173B2/en active Active
-
2019
- 2019-09-09 US US16/564,537 patent/US10918658B2/en active Active
-
2021
- 2021-01-27 US US17/159,735 patent/US11766448B2/en active Active
-
2023
- 2023-08-15 US US18/450,130 patent/US20240082288A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2826316A1 (en) | 2012-08-23 |
| KR101956885B1 (ko) | 2019-03-12 |
| SG10202007803QA (en) | 2020-09-29 |
| US20240082288A1 (en) | 2024-03-14 |
| KR20140046407A (ko) | 2014-04-18 |
| TR201908020T4 (tr) | 2019-06-21 |
| EP2675902A1 (en) | 2013-12-25 |
| US10918658B2 (en) | 2021-02-16 |
| US11766448B2 (en) | 2023-09-26 |
| US20130323226A1 (en) | 2013-12-05 |
| DK2675902T3 (da) | 2019-06-03 |
| JP6224459B2 (ja) | 2017-11-01 |
| MX353930B (es) | 2018-02-02 |
| US9884071B2 (en) | 2018-02-06 |
| CN103502458A (zh) | 2014-01-08 |
| SG10201601110VA (en) | 2016-03-30 |
| HUE043921T2 (hu) | 2019-09-30 |
| US10406173B2 (en) | 2019-09-10 |
| SG192268A1 (en) | 2013-08-30 |
| EP2675902B1 (en) | 2019-03-27 |
| CN103502458B (zh) | 2016-11-16 |
| AU2012219380A1 (en) | 2013-08-29 |
| JP2014507154A (ja) | 2014-03-27 |
| CA2826316C (en) | 2021-04-27 |
| US20200101099A1 (en) | 2020-04-02 |
| US20210145857A1 (en) | 2021-05-20 |
| US20180185405A1 (en) | 2018-07-05 |
| AU2012219380B2 (en) | 2017-04-13 |
| WO2012112832A1 (en) | 2012-08-23 |
| ES2724800T3 (es) | 2019-09-16 |
| PL2675902T3 (pl) | 2019-08-30 |
| MX2013009538A (es) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013020734A2 (pt) | composições e métodos para alterar a especificidade do tecido e aprimorar a transferência gênica mediada por aav9 | |
| CO7200251A2 (es) | Composición y metodos para una transferencia génica altamente eficiente utilizando variantes de cápsides de aav | |
| BR112014009066A2 (pt) | dna triciclo-fosforotioato | |
| BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| BR112014000735A2 (pt) | genes e proteína para a síntese de alcanoil-coa | |
| BR112013032352A2 (pt) | doença tromboembólica | |
| BR112013030381A2 (pt) | reagentes e métodos para tratar doença dental | |
| BR112014013682A2 (pt) | composição para cuidado pessoal | |
| BR112013020466A2 (pt) | ferramenta para desinfecção eletrostática | |
| BR112014002638A2 (pt) | compostos de oligonucleo tídeo de fita dupla para tratar desordens de audição e equilíbrio | |
| DK2709656T3 (da) | Proteinmatrix-vaccinesammensætninger omfattende polykationer | |
| BR112013031760A2 (pt) | vacina contra coronavírus canino | |
| BR112013032534A2 (pt) | interface gráfica para usuário | |
| BR112013019518A2 (pt) | composições para cuidado oral. | |
| BR112013029637A2 (pt) | composições para cuidados orais | |
| BR112013023576A2 (pt) | composições e métodos para a terapia e diagnóstico de influenza | |
| BR112014010769A2 (pt) | métodos e composições para neuroproteção | |
| DK2672817T3 (da) | Forbedrede insekticide formuleringer | |
| FR2970171B1 (fr) | Deambulateur universel | |
| BR112013033256A2 (pt) | tampão e métodos para instalação e liberação do mesmo | |
| BR112014013684A2 (pt) | composição para cuidado pessoal | |
| ES1074173Y (es) | Pieza para solados | |
| ES1074376Y (es) | Trituradora mejorada para restos de poda | |
| PL395839A1 (pl) | Drukarka termotransferowa | |
| ES1074764Y (es) | Protector para espatulas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |